Psychedelics Inc.

Startups want to profit from psilocybin and LSD. They have the potential to heal millions.

Despite Covid-19, a crashing economy and formidable legal obstacles, a growing number of entrepreneurs and investors are betting that medicines derived from psychedelic drugs can become a real business and heal millions of people. They are joining the researchers, activists…